The implementation of critical pathways in gynecologic oncology in a managed care setting: A cost analysis

Kris Ghosh, Levi S. Downs, Luis A. Padilla, Karuna P. Murray, Leo B. Twiggs, Carol M. Letourneau, Linda F. Carson

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives. The aim of the study is to determine whether critical pathways can be implemented at an academic institution to limit cost, without compromising patient satisfaction and quality of care. Patients and methods. Patients undergoing a hysterectomy with either cervical or endometrial cancer were placed on specific critical pathways consecutively for an 18-month study period. Preoperative: teaching was intensified to educate the patient regarding expectations during the postoperative period. All patients were started on early feeding and patients were also placed on separate care pathways addressing pain and deep vein thrombosis prophylaxis. Total direct costs and patient satisfaction were obtained throughout the study period. During the year prior to care pathway implementation, patient data and direct costs were obtained for the preintervention group utilized for comparison. Postintervention groups were summarized every 6 months during the study period. Results. From January 1997 through June 1998, 63 patients with cervical carcinoma undergoing a radical hysterectomy (DRG 353) and 21 patients with endometrial cancer who underwent a hysterectomy and lymph node sampling (DRG 355) were utilized as the preintervention group. During the 18-month study period (July 1998-December 1999), 42 patients (DRG 353) and 25 patients (DRG 355) were accrued. The average length of stay was reduced from 5.2 (DRG 353) and 4.7 days (DRG 355) prior to implementation of pathways to 3.4 days in both groups. In addition, total direct costs were reduced by 29 (DRG 353) and 32% (DRG 355) after implementation of care pathways. Patient satisfaction data recorded during the study did not demonstrate any change throughout the study period nor were there any higher rates of readmission after implementation of the care pathways. Conclusions. Critical pathways in gynecologic oncology can be implemented in a managed care environment in order to maintain high quality of care, maintain outcomes, and help reduce COSTS.

Original languageEnglish
Pages (from-to)378-382
Number of pages5
JournalGynecologic Oncology
Volume83
Issue number2
DOIs
StatePublished - Nov 15 2001
Externally publishedYes

Fingerprint

Critical Pathways
Managed Care Programs
Costs and Cost Analysis
Diagnosis-Related Groups
Hysterectomy
Patient Satisfaction
Quality of Health Care
Endometrial Neoplasms
Postoperative Period
Venous Thrombosis
Uterine Cervical Neoplasms
Length of Stay
Teaching

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Ghosh, K., Downs, L. S., Padilla, L. A., Murray, K. P., Twiggs, L. B., Letourneau, C. M., & Carson, L. F. (2001). The implementation of critical pathways in gynecologic oncology in a managed care setting: A cost analysis. Gynecologic Oncology, 83(2), 378-382. https://doi.org/10.1006/gyno.2001.6428

The implementation of critical pathways in gynecologic oncology in a managed care setting : A cost analysis. / Ghosh, Kris; Downs, Levi S.; Padilla, Luis A.; Murray, Karuna P.; Twiggs, Leo B.; Letourneau, Carol M.; Carson, Linda F.

In: Gynecologic Oncology, Vol. 83, No. 2, 15.11.2001, p. 378-382.

Research output: Contribution to journalArticle

Ghosh, K, Downs, LS, Padilla, LA, Murray, KP, Twiggs, LB, Letourneau, CM & Carson, LF 2001, 'The implementation of critical pathways in gynecologic oncology in a managed care setting: A cost analysis', Gynecologic Oncology, vol. 83, no. 2, pp. 378-382. https://doi.org/10.1006/gyno.2001.6428
Ghosh, Kris ; Downs, Levi S. ; Padilla, Luis A. ; Murray, Karuna P. ; Twiggs, Leo B. ; Letourneau, Carol M. ; Carson, Linda F. / The implementation of critical pathways in gynecologic oncology in a managed care setting : A cost analysis. In: Gynecologic Oncology. 2001 ; Vol. 83, No. 2. pp. 378-382.
@article{0bff4dfc59f34e5594bc19e6ddba9a0d,
title = "The implementation of critical pathways in gynecologic oncology in a managed care setting: A cost analysis",
abstract = "Objectives. The aim of the study is to determine whether critical pathways can be implemented at an academic institution to limit cost, without compromising patient satisfaction and quality of care. Patients and methods. Patients undergoing a hysterectomy with either cervical or endometrial cancer were placed on specific critical pathways consecutively for an 18-month study period. Preoperative: teaching was intensified to educate the patient regarding expectations during the postoperative period. All patients were started on early feeding and patients were also placed on separate care pathways addressing pain and deep vein thrombosis prophylaxis. Total direct costs and patient satisfaction were obtained throughout the study period. During the year prior to care pathway implementation, patient data and direct costs were obtained for the preintervention group utilized for comparison. Postintervention groups were summarized every 6 months during the study period. Results. From January 1997 through June 1998, 63 patients with cervical carcinoma undergoing a radical hysterectomy (DRG 353) and 21 patients with endometrial cancer who underwent a hysterectomy and lymph node sampling (DRG 355) were utilized as the preintervention group. During the 18-month study period (July 1998-December 1999), 42 patients (DRG 353) and 25 patients (DRG 355) were accrued. The average length of stay was reduced from 5.2 (DRG 353) and 4.7 days (DRG 355) prior to implementation of pathways to 3.4 days in both groups. In addition, total direct costs were reduced by 29 (DRG 353) and 32{\%} (DRG 355) after implementation of care pathways. Patient satisfaction data recorded during the study did not demonstrate any change throughout the study period nor were there any higher rates of readmission after implementation of the care pathways. Conclusions. Critical pathways in gynecologic oncology can be implemented in a managed care environment in order to maintain high quality of care, maintain outcomes, and help reduce COSTS.",
author = "Kris Ghosh and Downs, {Levi S.} and Padilla, {Luis A.} and Murray, {Karuna P.} and Twiggs, {Leo B.} and Letourneau, {Carol M.} and Carson, {Linda F.}",
year = "2001",
month = "11",
day = "15",
doi = "10.1006/gyno.2001.6428",
language = "English",
volume = "83",
pages = "378--382",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The implementation of critical pathways in gynecologic oncology in a managed care setting

T2 - A cost analysis

AU - Ghosh, Kris

AU - Downs, Levi S.

AU - Padilla, Luis A.

AU - Murray, Karuna P.

AU - Twiggs, Leo B.

AU - Letourneau, Carol M.

AU - Carson, Linda F.

PY - 2001/11/15

Y1 - 2001/11/15

N2 - Objectives. The aim of the study is to determine whether critical pathways can be implemented at an academic institution to limit cost, without compromising patient satisfaction and quality of care. Patients and methods. Patients undergoing a hysterectomy with either cervical or endometrial cancer were placed on specific critical pathways consecutively for an 18-month study period. Preoperative: teaching was intensified to educate the patient regarding expectations during the postoperative period. All patients were started on early feeding and patients were also placed on separate care pathways addressing pain and deep vein thrombosis prophylaxis. Total direct costs and patient satisfaction were obtained throughout the study period. During the year prior to care pathway implementation, patient data and direct costs were obtained for the preintervention group utilized for comparison. Postintervention groups were summarized every 6 months during the study period. Results. From January 1997 through June 1998, 63 patients with cervical carcinoma undergoing a radical hysterectomy (DRG 353) and 21 patients with endometrial cancer who underwent a hysterectomy and lymph node sampling (DRG 355) were utilized as the preintervention group. During the 18-month study period (July 1998-December 1999), 42 patients (DRG 353) and 25 patients (DRG 355) were accrued. The average length of stay was reduced from 5.2 (DRG 353) and 4.7 days (DRG 355) prior to implementation of pathways to 3.4 days in both groups. In addition, total direct costs were reduced by 29 (DRG 353) and 32% (DRG 355) after implementation of care pathways. Patient satisfaction data recorded during the study did not demonstrate any change throughout the study period nor were there any higher rates of readmission after implementation of the care pathways. Conclusions. Critical pathways in gynecologic oncology can be implemented in a managed care environment in order to maintain high quality of care, maintain outcomes, and help reduce COSTS.

AB - Objectives. The aim of the study is to determine whether critical pathways can be implemented at an academic institution to limit cost, without compromising patient satisfaction and quality of care. Patients and methods. Patients undergoing a hysterectomy with either cervical or endometrial cancer were placed on specific critical pathways consecutively for an 18-month study period. Preoperative: teaching was intensified to educate the patient regarding expectations during the postoperative period. All patients were started on early feeding and patients were also placed on separate care pathways addressing pain and deep vein thrombosis prophylaxis. Total direct costs and patient satisfaction were obtained throughout the study period. During the year prior to care pathway implementation, patient data and direct costs were obtained for the preintervention group utilized for comparison. Postintervention groups were summarized every 6 months during the study period. Results. From January 1997 through June 1998, 63 patients with cervical carcinoma undergoing a radical hysterectomy (DRG 353) and 21 patients with endometrial cancer who underwent a hysterectomy and lymph node sampling (DRG 355) were utilized as the preintervention group. During the 18-month study period (July 1998-December 1999), 42 patients (DRG 353) and 25 patients (DRG 355) were accrued. The average length of stay was reduced from 5.2 (DRG 353) and 4.7 days (DRG 355) prior to implementation of pathways to 3.4 days in both groups. In addition, total direct costs were reduced by 29 (DRG 353) and 32% (DRG 355) after implementation of care pathways. Patient satisfaction data recorded during the study did not demonstrate any change throughout the study period nor were there any higher rates of readmission after implementation of the care pathways. Conclusions. Critical pathways in gynecologic oncology can be implemented in a managed care environment in order to maintain high quality of care, maintain outcomes, and help reduce COSTS.

UR - http://www.scopus.com/inward/record.url?scp=0034766561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034766561&partnerID=8YFLogxK

U2 - 10.1006/gyno.2001.6428

DO - 10.1006/gyno.2001.6428

M3 - Article

C2 - 11606100

AN - SCOPUS:0034766561

VL - 83

SP - 378

EP - 382

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -